Immunic AG | Finanzwire

BRIEF

published on 07/24/2024 at 12:35, 3 months 30 days ago

Immunic, Inc. Strengthens Its Board with Appointment of Simona Skerjanec

Drug Development Board Appointment Immunic Simona Skerjanec Pharmaceutical Experience
PRESS RELEASE

published on 07/24/2024 at 12:30, 3 months 30 days ago

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
Immunic, Inc. strengthens its board with the appointment of experienced pharmaceutical executive Simona Skerjanec, known for leading successful commercial launches in MS therapy

Board Appointment Immunic Inc. MS Therapy Simona Skerjanec Pharmaceutical Executive
BRIEF

published on 07/09/2024 at 12:35, 4 months 14 days ago

Immunic Appoints Jason Tardio as Chief Operating Officer and President

Multiple Sclerosis Immunic Vidofludimus Calcium COO Appointment Jason Tardio
PRESS RELEASE

published on 07/09/2024 at 12:30, 4 months 14 days ago

Immunic Appoints Jason Tardio as Chief Operating Officer and President
Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer

Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF

published on 05/28/2024 at 12:35, 5 months 26 days ago

Immunic to Participate in Industry and Scientific Conferences in June

Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
PRESS RELEASE

published on 05/28/2024 at 12:30, 5 months 26 days ago

Immunic to Participate in Industry and Scientific Conferences in June
Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases

Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF

published on 05/08/2024 at 12:35, 6 months 15 days ago

Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates

Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
PRESS RELEASE

published on 05/08/2024 at 12:30, 6 months 15 days ago

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies

Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF

published on 05/06/2024 at 12:35, 6 months 17 days ago

Immunic AG Announces Participation in May Conferences for Investor and Scientific Communities

Investor Conferences Clinical Trials Immunic AG Scientific Conferences Autoimmune Disease Treatments
PRESS RELEASE

published on 05/06/2024 at 12:30, 6 months 17 days ago

Immunic to Participate in Investor and Scientific Conferences in May
Immunic, Inc. to participate in investor and scientific conferences in May, presenting clinical trial data on oral therapies for inflammatory diseases

Investor Conferences Clinical Trials Immunic Inc. Inflammatory Diseases Scientific Conferences

Published on 11/22/2024 at 23:55, 23 hours 19 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 23 hours 44 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 4 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 5 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 5 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 6 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 7 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 8 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 16 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 3 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 5 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News